The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((5-cyclopropyl-1H-pyrrol-2-yl)methylene)-7-fluoro-5-(8-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl)indolin-2-one ID: ALA4758698
PubChem CID: 162658671
Max Phase: Preclinical
Molecular Formula: C24H21FN4O2
Molecular Weight: 416.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(-c2cc(F)c3c(c2)/C(=C/c2ccc(C4CC4)[nH]2)C(=O)N3)cnc2c1NCCO2
Standard InChI: InChI=1S/C24H21FN4O2/c1-12-18(11-27-24-21(12)26-6-7-31-24)14-8-16-17(23(30)29-22(16)19(25)9-14)10-15-4-5-20(28-15)13-2-3-13/h4-5,8-11,13,26,28H,2-3,6-7H2,1H3,(H,29,30)/b17-10-
Standard InChI Key: FFWIIJDLELGDJL-YVLHZVERSA-N
Molfile:
RDKit 2D
31 36 0 0 0 0 0 0 0 0999 V2000
6.6581 -19.3778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3745 -18.9645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3717 -18.1340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6562 -17.7248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0861 -19.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0861 -20.2012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5112 -19.3696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7963 -18.9620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5151 -20.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8040 -20.6100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8045 -21.4269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5145 -21.8389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2258 -21.4278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2269 -20.6046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3728 -20.6159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9433 -18.9649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9400 -18.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1549 -17.8890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6731 -18.5580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1604 -19.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8480 -18.5613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9086 -20.0084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1024 -20.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4860 -19.6386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7732 -20.0540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9480 -20.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7688 -20.9432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0182 -19.7215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6536 -16.8998 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5283 -19.0541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1958 -19.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 17 1 0
5 6 2 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
2 5 1 0
9 10 2 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
6 15 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
19 21 2 0
20 22 2 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 2 0
25 28 1 0
4 29 1 0
30 28 1 0
31 30 1 0
28 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.46Molecular Weight (Monoisotopic): 416.1649AlogP: 4.70#Rotatable Bonds: 3Polar Surface Area: 79.04Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.60CX Basic pKa: 3.47CX LogP: 3.71CX LogD: 3.71Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.54Np Likeness Score: -0.12